News Release Details
Verrica Pharmaceuticals to Attend Several Upcoming Investor Conferences
Cowen 40th Annual
Oppenheimer 30th Annual Healthcare Conference
1x1 Meetings Only – No Presentation
Live webcasts of the presentations can be accessed at the company’s Investors page under Events and Presentations at https://investors.verrica.com/events-and-presentations. Webcast replays will also be available on this website shortly after conclusion of the event for 30 days.
About Verrica Pharmaceuticals Inc.
Verrica is a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions. The Company’s late-stage product candidate, VP-102, is a potential first-in-class topical therapy for the treatment of molluscum contagiosum and common warts. Molluscum is a highly contagious viral skin infection affecting approximately six million people, primarily children, in the United States, and common warts are contagious skin growths affecting 22 million people. There are currently no
FOR MORE INFORMATION, PLEASE CONTACT:
Chief Financial Officer
484.453.3300 ext. 103
Source: Verrica Pharmaceuticals Inc.